Global Paget Disease Treatment Market Forecasted to Grow Steadily at 3.6% CAGR Between 2025 and 2029
Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
What Is the Predicted Market Size and CAGR of the Paget Disease Treatment Market by the End of the 2029?
The paget disease treatment market size has grown steadily in recent years. It will grow from $2.12 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to rising prevalence of paget disease, increasing awareness and diagnosis rates, growing geriatric population, increasing healthcare infrastructure, and growing adoption of bisphosphonates.
The paget disease treatment market size is expected to see steady growth in the next few years. It will grow to " $2.52 billion in 2029 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to rising demand for targeted therapies, increasing healthcare expenditure, growing aging population, rising clinical trials for novel therapies, and increasing focus on personalized medicine. Major trends in the forecast period include advancements in treatment options, shift towards biologic treatments, development of combination therapies, integration of digital health solutions, and advancements in diagnostic technologies.
Get your free report sample today:
Which Factors Are Contributing Most to the Expansion of the Paget Disease Treatment Market?
The rise in the number of cases related to arthritis and bone injuries is expected to propel the growth of the paget disease treatment market going forward. Arthritis is a condition that causes joint inflammation, whereas bone injuries can contribute to its development. The rise in arthritis and bone injuries can be attributed to a lack of physical activity, which weakens muscles and joints, reducing their ability to support movement and absorb impact. This increases the risk of joint degeneration, stiffness, and fractures over time. Paget disease treatment helps manage arthritis and bone injuries by reducing bone pain, improving joint function, and preventing complications such as fractures and deformities caused by abnormal bone remodeling. For instance, February 2024, according to The Centers for Disease Control and Prevention (CDC), US-based national public health institute, in 2022, the age-adjusted prevalence of diagnosed arthritis among adults aged 18 and older was 18.9%, with women (21.5%) exhibiting a higher incidence compared to men (16.1%). The prevalence of arthritis increased with age, ranging from 3.6% in individuals aged 18–34 to 53.9% in those aged 75 and above. Therefore, the rise in the number of cases related to arthritis and bone injuries is driving growth in the paget disease treatment market.
Which Key Segments Are Included in the Paget Disease Treatment Market Analysis?
The paget disease treatmentmarket covered in this report is segmented –
1) By Treatment Type: Actonel; Reclast; Zoledronic Acid; Fosamax; Miacalcin; Aredia; Calcitonin; Zometa; Other Treatments
2) By Route Of Administration: Oral; Intravenous; Topical
3) By Distribution Channels: Hospital Pharmacies; Retail Pharmacies; Online Pharmacie; Drug stores
4) By End User: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Actonel: Risedronate Sodium Tablets; Delayed-Release Risedronate.
2) By Reclast: Intravenous Reclast; Annual Reclast Infusion.
3) By Zoledronic Acid: Zoledronic Acid 5 mg Injection; Zoledronic Acid 4 mg Injection.
4) By Fosamax: Alendronate Sodium Tablets; Alendronate Oral Solution
5) By Miacalcin: Miacalcin Nasal Spray; Miacalcin Injection
6) By Aredia: Pamidronate Disodium 30 mg Injection; Pamidronate Disodium 90 mg Injection
7) By Calcitonin: Synthetic Salmon Calcitonin; Human Calcitonin
8) By Zometa: Zometa 4 mg/5 mL Concentrate; Zometa 4 mg Infusion
9) By Other Treatments: Pain Management Medications; Physical Therapy; Surgical Interventions
Which Major Trends Are Expected to Define the Paget Disease Treatment Market Through 2029?
Major companies operating in the paget disease treatment market are focusing on innovative product development, such as calcium regulator, to enhance treatment efficacy, improve patient outcomes, and expand their market presence. A calcium regulator is a substance or medication that helps control the levels of calcium in the blood and bones, maintaining balance to support various physiological functions. For instance, in February 2025, Fresenius Kabi AG, a Germany-based healthcare company, launched Calcitonin Salmon Injection, USP Synthetic, a calcium regulator designed to treat symptomatic Paget’s disease of the bone, hypercalcemia, and postmenopausal osteoporosis. This launch is aimed at offering a more cost-effective treatment option, strengthening their supply chain, and expanding their portfolio of generic injectables. Fresenius Kabi has made substantial investments in its facilities to guarantee a steady supply of essential medicines, with the objective of enhancing patient care and establishing itself as a leading healthcare provider.
Who Are the Top Industry Players Driving the Paget Disease Treatment Market Growth?
Major companies operating in the paget disease treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Apotex Inc., Sumitomo Pharma Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Endo International plc, Zaklady Farmaceutyczne Polpharma S.A., Abiogen Pharma S.p.A.
Get the detailed paget disease treatment market report today
Which Regional Markets Offer the Most Promising Growth Opportunities for the Paget Disease Treatment Market?
North America was the largest region in the paget disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the paget disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment